Anthem INC (ANTM) Shareholder Focused Investors LLC Decreased Stake by $4.42 Million as Valuation Declined

September 7, 2018 - By Richard Slagle

Anthem, Inc. (NYSE:ANTM) Logo

Focused Investors Llc decreased its stake in Anthem Inc. (ANTM) by 2.8% based on its latest 2018Q1 regulatory filing with the SEC. Focused Investors Llc sold 20,200 shares as the company’s stock declined 2.45% with the market. The institutional investor held 702,300 shares of the health care company at the end of 2018Q1, valued at $154.30M, down from 722,500 at the end of the previous reported quarter. Focused Investors Llc who had been investing in Anthem Inc. for a number of months, seems to be less bullish one the $70.78B market cap company. The stock increased 0.79% or $2.14 during the last trading session, reaching $272.28. About 678,032 shares traded. Anthem, Inc. (NYSE:ANTM) has risen 28.04% since September 7, 2017 and is uptrending. It has outperformed by 15.47% the S&P500.

Focused Investors Llc, which manages about $2.82B and $2.29 billion US Long portfolio, upped its stake in Johnson & Johnson (NYSE:JNJ) by 47,100 shares to 1.14M shares, valued at $145.72 million in 2018Q1, according to the filing.

Analysts await Anthem, Inc. (NYSE:ANTM) to report earnings on October, 24. They expect $3.66 EPS, up 38.11 % or $1.01 from last year’s $2.65 per share. ANTM’s profit will be $951.43 million for 18.60 P/E if the $3.66 EPS becomes a reality. After $4.25 actual EPS reported by Anthem, Inc. for the previous quarter, Wall Street now forecasts -13.88 % negative EPS growth.

More important recent Anthem, Inc. (NYSE:ANTM) news were published by: 247Wallst.com which released: “Meet Walmart’s Newest Partner” on August 20, 2018, also Seekingalpha.com published article titled: “Tracking Ole Andreas Halvorsen’s Viking Global Portfolio – Q2 2018 Update”, Benzinga.com published: “Morgan Stanley Upgrades Anthem, Sees Opportunity In Pharmacy Benefit Manager Shakeup” on September 05, 2018. More interesting news about Anthem, Inc. (NYSE:ANTM) was released by: Seekingalpha.com and their article: “Premarket analyst action – healthcare” with publication date: September 05, 2018.

Anthem, Inc. (NYSE:ANTM) Ratings Coverage

Among 10 analysts covering Anthem (NYSE:ANTM), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Anthem had 11 analyst reports since March 8, 2018 according to SRatingsIntel. The firm has “Overweight” rating by Morgan Stanley given on Wednesday, September 5. On Thursday, April 26 the stock rating was maintained by Credit Suisse with “Outperform”. On Monday, July 9 the stock rating was upgraded by BMO Capital Markets to “Outperform”. The firm has “Buy” rating by Bernstein given on Thursday, April 26. Leerink Swann maintained the stock with “Buy” rating in Friday, March 9 report. RBC Capital Markets maintained Anthem, Inc. (NYSE:ANTM) on Wednesday, April 25 with “Buy” rating. JP Morgan upgraded the stock to “Overweight” rating in Thursday, April 26 report. On Wednesday, April 25 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The stock of Anthem, Inc. (NYSE:ANTM) has “Equal-Weight” rating given on Thursday, July 26 by Morgan Stanley. J.P. Morgan upgraded the stock to “Buy” rating in Thursday, April 26 report.

Anthem, Inc. (NYSE:ANTM) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.